Will AbbVie’s $10.9 Billion Acquisition Shape Its Dividend?
AbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
This article compares Zero Based Budgeting and Incremental Budgeting, showing practical differences, use cases, and potential impacts on your budget.
18,304 articlesAbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
A Middle East crisis sent oil prices higher and spotlighted a rapid shift to electric vehicles. New data show the wor...
Market turbulence can be unsettling, but it also creates opportunities for disciplined investors. This guide lays out...
Iran has quietly formalized yuan-based fees for ships passing the Strait of Hormuz as U.S. forces position nearby. Th...
Oil traded at $106.52 per barrel for Brent on May 6, 2026, at 8:30 a.m. ET, marking a sharp drop from yesterday and s...
Most income investors have long searched for steady monthly cash flow, and these NASDAQ-focused ETFs offer a new appr...
A wave of Class of 2026 graduates is moving back home as costs rise. This story explains how families can support sav...
AI is moving from chat to your wallet. OpenAI has rolled a personal finance dashboard for Pro users, raising question...
Reality TV figure Spencer Pratt publicly challenges Karen Bass, signaling a hard line on budget reform. The confronta...
Start your week with purpose. These Monday reads distill market signals, tech shifts, and personal-finance moves into...
Forecasters warn the 2026 El Niño could be one of the strongest on record, risking broad economic shocks and volatile...
Europe’s move toward UN-led tax dialogue signals a broader shift in global rules. This article breaks down what that ...